GodelaBrosnahanGodela M. Brosnahan39.74515960000000-104.840628000000001595Brosnahan, GodelaM.303/724-1687Affiliateprns:coAuthorOfcoauthor ofprns:emailEncryptedemail addressprns:endDateend dateFaculty Rankprns:fullNamefull nameprns:grantAwardedBygrant awarded byprns:hasAuthorListauthor listprns:hasFacultyRankhas faculty rankprns:hasNetworkhas networkprns:hasPublicationVenuepublished inprns:informationResourceReferenceinformation resource referenceprns:isPrimaryPositionis primary positionprns:latitudelatitudeprns:longitudelongitudeprns:mainImagephotoprns:maxWeightmaximum weightprns:medlineTAjournal title abbreviationprns:meshDescriptorUIMeSH DescriptorUIprns:meshSemanticGroupNameMeSH semantic group nameprns:minWeightminimum weightprns:numberOfAuthorsnumber of authorsprns:numberOfConnectionsnumber of connectionsprns:numberOfPublicationsnumber of publicationsprns:personIdPerson IDprns:personInPrimaryPositionperson in primary positionprns:physicalNeighborOfphysical neighborprns:positionInDepartmentposition in departmentprns:positionInDivisionposition in divisionprns:predicateNodepredicate nodeprns:principalInvestigatorNameprincipal investigator nameprns:publicationDatepublication dateprns:similarTosimilar toprns:sortOrdersort orderprns:startDatestart dateprns:uniquenessWeightuniqueness weightprns:yearyearAcademic ArticleArticleDocumentbibo:pmidPubMed IdentifierAddressvivo:address3address line 3vivo:addressCitycityvivo:addressPostalCodepostal codevivo:addressStatestate or provinceAgreementvivo:authorInAuthorshipselected publicationsvivo:authorRankauthor rank in publicationAuthorshipDepartmentDivisionGrantvivo:hasResearchArearesearch areasvivo:hasResearcherRoleresearch activitiesvivo:hrJobTitleHR job titleInformation Resourcevivo:linkedAuthorlinked authorvivo:linkedInformationResourcelinked information resourcevivo:mailingAddressmailing addressvivo:middleNamemiddle name or initialvivo:orcidIdORCID idvivo:personInPositionpositionsvivo:phoneNumberphonePositionvivo:positionInOrganizationposition in organizationvivo:preferredTitlepreferred titleResearcher Rolevivo:researcherRoleOfresearcher role ofRolevivo:roleContributesTocontributes tovivo:sponsorAwardIdsponsor award idrdf:predicatepredicaterdf:typetyperdfs:labellabelConceptAgentfoaf:firstNamefirst namefoaf:lastNamelast nameOrganizationPersonAuthorship 826594Authorship 834173Authorship 1188409Authorship 11896814Authorship 1191148Authorship 119130825399731Torres VE, Abebe KZ, Chapman AB, Schrier RW, Braun WE, Steinman TI, Winklhofer FT, Brosnahan G, Czarnecki PG, Hogan MC, Miskulin DC, Rahbari-Oskoui FF, Grantham JJ, Harris PC, Flessner MF, Moore CG, Perrone RDThe New England journal of medicineTorres VE, Abebe KZ, Chapman AB, Schrier RW, Braun WE, Steinman TI, Winklhofer FT, Brosnahan G, Czarnecki PG, Hogan MC, Miskulin DC, Rahbari-Oskoui FF, Grantham JJ, Harris PC, Flessner MF, Moore CG, Perrone RD. Angiotensin blockade in late autosomal dominant polycystic kidney disease. N Engl J Med. 2014 Dec 11; 371(24):2267-76.N Engl J Med2014-11-15T00:00:002014Angiotensin blockade in late autosomal dominant polycystic kidney disease.25399733Schrier RW, Abebe KZ, Perrone RD, Torres VE, Braun WE, Steinman TI, Winklhofer FT, Brosnahan G, Czarnecki PG, Hogan MC, Miskulin DC, Rahbari-Oskoui FF, Grantham JJ, Harris PC, Flessner MF, Bae KT, Moore CG, Chapman ABThe New England journal of medicineSchrier RW, Abebe KZ, Perrone RD, Torres VE, Braun WE, Steinman TI, Winklhofer FT, Brosnahan G, Czarnecki PG, Hogan MC, Miskulin DC, Rahbari-Oskoui FF, Grantham JJ, Harris PC, Flessner MF, Bae KT, Moore CG, Chapman AB. Blood pressure in early autosomal dominant polycystic kidney disease. N Engl J Med. 2014 Dec 11; 371(24):2255-66.N Engl J Med2014-11-15T00:00:002014Blood pressure in early autosomal dominant polycystic kidney disease.25111236Hogan MC, Abebe K, Torres VE, Chapman AB, Bae KT, Tao C, Sun H, Perrone RD, Steinman TI, Braun W, Winklhofer FT, Miskulin DC, Rahbari-Oskoui F, Brosnahan G, Masoumi A, Karpov IO, Spillane S, Flessner M, Moore CG, Schrier RWClinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological AssociationHogan MC, Abebe K, Torres VE, Chapman AB, Bae KT, Tao C, Sun H, Perrone RD, Steinman TI, Braun W, Winklhofer FT, Miskulin DC, Rahbari-Oskoui F, Brosnahan G, Masoumi A, Karpov IO, Spillane S, Flessner M, Moore CG, Schrier RW. Liver involvement in early autosomal-dominant polycystic kidney disease. Clin Gastroenterol Hepatol. 2015 Jan; 13(1):155-64.e6.Clin Gastroenterol Hepatol2014-08-09T00:00:002014Liver involvement in early autosomal-dominant polycystic kidney disease.25234311Klawitter J, Reed-Gitomer BY, McFann K, Pennington A, Klawitter J, Abebe KZ, Klepacki J, Cadnapaphornchai MA, Brosnahan G, Chonchol M, Christians U, Schrier RWAmerican journal of physiology. Renal physiologyKlawitter J, Reed-Gitomer BY, McFann K, Pennington A, Klawitter J, Abebe KZ, Klepacki J, Cadnapaphornchai MA, Brosnahan G, Chonchol M, Christians U, Schrier RW. Endothelial dysfunction and oxidative stress in polycystic kidney disease. Am J Physiol Renal Physiol. 2014 Dec 01; 307(11):F1198-206.Am J Physiol Renal Physiol2014-09-18T00:00:002014Endothelial dysfunction and oxidative stress in polycystic kidney disease.Authorship 867091Authorship 121274125567505Brosnahan GCurrent hypertension reviewsBrosnahan G. Treatment of hypertension in chronic kidney disease: does one size fit all? A narrative review from a nephrologist's perspective. Curr Hypertens Rev. 2014; 10(3):155-65.Curr Hypertens Rev2014-01-01T00:00:002014Treatment of hypertension in chronic kidney disease: does one size fit all? A narrative review from a nephrologist's perspective.KatharinaHopp++kUZ7yusATQVQI5a3vXgUREUZQSFFmsEypJ1OI=Katharina Hopp39.74515960000000-104.8406280000000010111Hopp, KatharinaAsst ProfessorZhiyingYouZhiying You39.74515960000000-104.8406280000000010914You, ZhiyingAssoc Professor-ResearchAuthorship 142742624343898Klawitter J, Klawitter J, McFann K, Pennington AT, Abebe KZ, Brosnahan G, Cadnapaphornchai MA, Chonchol M, Gitomer B, Christians U, Schrier RWJournal of lipid researchKlawitter J, Klawitter J, McFann K, Pennington AT, Abebe KZ, Brosnahan G, Cadnapaphornchai MA, Chonchol M, Gitomer B, Christians U, Schrier RW. Bioactive lipid mediators in polycystic kidney disease. J Lipid Res. 2014 06; 55(6):1139-49.J Lipid Res2013-12-16T00:00:002013Bioactive lipid mediators in polycystic kidney disease.Authorship 1478741426823553Heyer CM, Sundsbak JL, Abebe KZ, Chapman AB, Torres VE, Grantham JJ, Bae KT, Schrier RW, Perrone RD, Braun WE, Steinman TI, Mrug M, Yu AS, Brosnahan G, Hopp K, Irazabal MV, Bennett WM, Flessner MF, Moore CG, Landsittel D, Harris PCJournal of the American Society of Nephrology : JASNHeyer CM, Sundsbak JL, Abebe KZ, Chapman AB, Torres VE, Grantham JJ, Bae KT, Schrier RW, Perrone RD, Braun WE, Steinman TI, Mrug M, Yu AS, Brosnahan G, Hopp K, Irazabal MV, Bennett WM, Flessner MF, Moore CG, Landsittel D, Harris PC. Predicted Mutation Strength of Nontruncating PKD1 Mutations Aids Genotype-Phenotype Correlations in Autosomal Dominant Polycystic Kidney Disease. J Am Soc Nephrol. 2016 09; 27(9):2872-84.J Am Soc Nephrol2016-01-28T00:00:002016Predicted Mutation Strength of Nontruncating PKD1 Mutations Aids Genotype-Phenotype Correlations in Autosomal Dominant Polycystic Kidney Disease.10692268Ecder T, Chapman AB, Brosnahan GM, Edelstein CL, Johnson AM, Schrier RWAmerican journal of kidney diseases : the official journal of the National Kidney FoundationEcder T, Chapman AB, Brosnahan GM, Edelstein CL, Johnson AM, Schrier RW. Effect of antihypertensive therapy on renal function and urinary albumin excretion in hypertensive patients with autosomal dominant polycystic kidney disease. Am J Kidney Dis. 2000 Mar; 35(3):427-32.Am J Kidney Dis2000-03-01T00:00:002000Effect of antihypertensive therapy on renal function and urinary albumin excretion in hypertensive patients with autosomal dominant polycystic kidney disease.11095651Persu A, Devuyst O, Lannoy N, Materne R, Brosnahan G, Gabow PA, Pirson Y, Verellen-Dumoulin CJournal of the American Society of Nephrology : JASNPersu A, Devuyst O, Lannoy N, Materne R, Brosnahan G, Gabow PA, Pirson Y, Verellen-Dumoulin C. CF gene and cystic fibrosis transmembrane conductance regulator expression in autosomal dominant polycystic kidney disease. J Am Soc Nephrol. 2000 Dec; 11(12):2285-2296.J Am Soc Nephrol2000-12-01T00:00:002000CF gene and cystic fibrosis transmembrane conductance regulator expression in autosomal dominant polycystic kidney disease.Authorship 1514011226231556Moore CG, Spillane S, Simon G, Maxwell B, Rahbari-Oskoui FF, Braun WE, Chapman AB, Schrier RW, Torres VE, Perrone RD, Steinman TI, Brosnahan G, Czarnecki PG, Harris PC, Miskulin DC, Flessner MF, Bae KT, Abebe KZ, Hogan MCContemporary clinical trialsMoore CG, Spillane S, Simon G, Maxwell B, Rahbari-Oskoui FF, Braun WE, Chapman AB, Schrier RW, Torres VE, Perrone RD, Steinman TI, Brosnahan G, Czarnecki PG, Harris PC, Miskulin DC, Flessner MF, Bae KT, Abebe KZ, Hogan MC. Closeout of the HALT-PKD trials. Contemp Clin Trials. 2015 Sep; 44:48-55.Contemp Clin Trials2015-07-29T00:00:002015Closeout of the HALT-PKD trials.Authorship 154381927993381Torres VE, Abebe KZ, Schrier RW, Perrone RD, Chapman AB, Yu AS, Braun WE, Steinman TI, Brosnahan G, Hogan MC, Rahbari FF, Grantham JJ, Bae KT, Moore CG, Flessner MFKidney internationalTorres VE, Abebe KZ, Schrier RW, Perrone RD, Chapman AB, Yu AS, Braun WE, Steinman TI, Brosnahan G, Hogan MC, Rahbari FF, Grantham JJ, Bae KT, Moore CG, Flessner MF. Dietary salt restriction is beneficial to the management of autosomal dominant polycystic?kidney disease. Kidney Int. 2017 02; 91(2):493-500.Kidney Int2016-12-16T00:00:002016Dietary salt restriction is beneficial to the management of autosomal dominant polycystic?kidney disease.5Other Faculty1Professor3Asst Professor2Assoc Professor4Instructor7Fellow or Post Doc2019-07-31NIHBROSNAHAN, GODELA M2016-08-20Feasibility study of metformin therapy in ADPKDR21DK107969Principal Investigator16914712Brosnahan GMThe New England journal of medicineBrosnahan GM. Volume progression in polycystic kidney disease. N Engl J Med. 2006 Aug 17; 355(7):733; author reply 733-4.N Engl J Med2006-08-17T00:00:002006Volume progression in polycystic kidney disease.12700 E. 19th Ave.12700 E. 19th Ave.Aurora80045-2560CO17936432Barone GW, Wright CF, Krause MW, Brosnahan GM, Portilla D, Banerjee S, McCowan TC, Culp WC, Yousaf MAmerican journal of surgeryBarone GW, Wright CF, Krause MW, Brosnahan GM, Portilla D, Banerjee S, McCowan TC, Culp WC, Yousaf M. Hemodialysis access success: beyond the operating room. Am J Surg. 2007 Nov; 194(5):668-71.Am J Surg2007-11-01T00:00:002007Hemodialysis access success: beyond the operating room.18653899Brosnahan G, Gokden N, Swaminathan SNephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal AssociationBrosnahan G, Gokden N, Swaminathan S. Acute interstitial nephritis due to deferasirox: a case report. Nephrol Dial Transplant. 2008 Oct; 23(10):3356-8.Nephrol Dial Transplant2008-07-24T00:00:002008Acute interstitial nephritis due to deferasirox: a case report.10344347Ecder T, Edelstein CL, Chapman AB, Johnson AM, Tison L, Gill EA, Brosnahan GM, Schrier RWNephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal AssociationEcder T, Edelstein CL, Chapman AB, Johnson AM, Tison L, Gill EA, Brosnahan GM, Schrier RW. Reversal of left ventricular hypertrophy with angiotensin converting enzyme inhibition in hypertensive patients with autosomal dominant polycystic kidney disease. Nephrol Dial Transplant. 1999 May; 14(5):1113-6.Nephrol Dial Transplant1999-05-01T00:00:001999Reversal of left ventricular hypertrophy with angiotensin converting enzyme inhibition in hypertensive patients with autosomal dominant polycystic kidney disease.20065899Brosnahan G, Fraer MSouthern medical journalBrosnahan G, Fraer M. Chronic kidney disease: whom to screen and how to treat, part 1: definition, epidemiology, and laboratory testing. South Med J. 2010 Feb; 103(2):140-6.South Med J2010-02-01T00:00:002010Chronic kidney disease: whom to screen and how to treat, part 1: definition, epidemiology, and laboratory testing.20134375Brosnahan G, Fraer MSouthern medical journalBrosnahan G, Fraer M. Management of chronic kidney disease: what is the evidence? South Med J. 2010 Mar; 103(3):222-30.South Med J2010-03-01T00:00:002010Management of chronic kidney disease: what is the evidence?Authorship 171231128460625Brosnahan GM, Abebe KZ, Rahbari-Oskoui FF, Patterson CG, Bae KT, Schrier RW, Braun WE, Chapman AB, Flessner MF, Harris PC, Perrone RD, Steinman TI, Torres VECurrent hypertension reviewsBrosnahan GM, Abebe KZ, Rahbari-Oskoui FF, Patterson CG, Bae KT, Schrier RW, Braun WE, Chapman AB, Flessner MF, Harris PC, Perrone RD, Steinman TI, Torres VE. Effect of Statin Therapy on the Progression of Autosomal Dominant Polycystic Kidney Disease. A Secondary Analysis of the HALT PKD Trials. Curr Hypertens Rev. 2017; 13(2):109-120.Curr Hypertens Rev2017-01-01T00:00:002017Effect of Statin Therapy on the Progression of Autosomal Dominant Polycystic Kidney Disease. A Secondary Analysis of the HALT PKD Trials.Authorship 172282429118087Nowak KL, You Z, Gitomer B, Brosnahan G, Torres VE, Chapman AB, Perrone RD, Steinman TI, Abebe KZ, Rahbari-Oskoui FF, Yu ASL, Harris PC, Bae KT, Hogan M, Miskulin D, Chonchol MJournal of the American Society of Nephrology : JASNNowak KL, You Z, Gitomer B, Brosnahan G, Torres VE, Chapman AB, Perrone RD, Steinman TI, Abebe KZ, Rahbari-Oskoui FF, Yu ASL, Harris PC, Bae KT, Hogan M, Miskulin D, Chonchol M. Overweight and Obesity Are Predictors of Progression in Early Autosomal Dominant Polycystic Kidney Disease. J Am Soc Nephrol. 2018 02; 29(2):571-578.J Am Soc Nephrol2017-11-08T00:00:002017Overweight and Obesity Are Predictors of Progression in Early Autosomal Dominant Polycystic Kidney Disease.12089368Schrier R, McFann K, Johnson A, Chapman A, Edelstein C, Brosnahan G, Ecder T, Tison LJournal of the American Society of Nephrology : JASNSchrier R, McFann K, Johnson A, Chapman A, Edelstein C, Brosnahan G, Ecder T, Tison L. Cardiac and renal effects of standard versus rigorous blood pressure control in autosomal-dominant polycystic kidney disease: results of a seven-year prospective randomized study. J Am Soc Nephrol. 2002 Jul; 13(7):1733-9.J Am Soc Nephrol2002-07-01T00:00:002002Cardiac and renal effects of standard versus rigorous blood pressure control in autosomal-dominant polycystic kidney disease: results of a seven-year prospective randomized study.19006913Banerjee S, Brosnahan GThe Journal of the Arkansas Medical SocietyBanerjee S, Brosnahan G. Polymyalgia rheumatica in a renal transplant patient. J Ark Med Soc. 2008 Nov; 105(5):115-7.J Ark Med Soc2008-11-01T00:00:002008Polymyalgia rheumatica in a renal transplant patient.Authorship 174490329203126Braun WE, Abebe KZ, Brosnahan G, Patterson CG, Chapman AB, Harris PC, Hogan MC, Perrone RD, Torres VE, Miskulin DC, Steinman TI, Winklhofer FT, Rahbari-Oskoui FF, Czarnecki PG, Bae KT, Grantham JJ, Flessner MF, Schrier RWAmerican journal of kidney diseases : the official journal of the National Kidney FoundationBraun WE, Abebe KZ, Brosnahan G, Patterson CG, Chapman AB, Harris PC, Hogan MC, Perrone RD, Torres VE, Miskulin DC, Steinman TI, Winklhofer FT, Rahbari-Oskoui FF, Czarnecki PG, Bae KT, Grantham JJ, Flessner MF, Schrier RW. ADPKD Progression in Patients With No Apparent Family History and No Mutation Detected by Sanger Sequencing. Am J Kidney Dis. 2018 02; 71(2):294-296.Am J Kidney Dis2017-12-02T00:00:002017ADPKD Progression in Patients With No Apparent Family History and No Mutation Detected by Sanger Sequencing.Authorship 174972129306517Brosnahan GM, Abebe KZ, Moore CG, Rahbari-Oskoui FF, Bae KT, Grantham JJ, Schrier RW, Braun WE, Chapman AB, Flessner MF, Harris PC, Hogan MC, Perrone RD, Miskulin DC, Steinman TI, Torres VEAmerican journal of kidney diseases : the official journal of the National Kidney FoundationBrosnahan GM, Abebe KZ, Moore CG, Rahbari-Oskoui FF, Bae KT, Grantham JJ, Schrier RW, Braun WE, Chapman AB, Flessner MF, Harris PC, Hogan MC, Perrone RD, Miskulin DC, Steinman TI, Torres VE. Patterns of Kidney Function Decline in Autosomal Dominant Polycystic Kidney Disease: A Post Hoc Analysis From the HALT-PKD Trials. Am J Kidney Dis. 2018 05; 71(5):666-676.Am J Kidney Dis2018-01-03T00:00:002018Patterns of Kidney Function Decline in Autosomal Dominant Polycystic Kidney Disease: A Post Hoc Analysis From the HALT-PKD Trials.Authorship 178980129564978Brosnahan GM, Abebe KZ, Moore CG, Bae KT, Braun WE, Chapman AB, Flessner MF, Harris PC, Hogan MC, Perrone RD, Rahbari-Oskoui FF, Steinman TI, Torres VECurrent hypertension reviewsBrosnahan GM, Abebe KZ, Moore CG, Bae KT, Braun WE, Chapman AB, Flessner MF, Harris PC, Hogan MC, Perrone RD, Rahbari-Oskoui FF, Steinman TI, Torres VE. Determinants of Progression in Early Autosomal Dominant Polycystic Kidney Disease: Is it Blood Pressure or Renin-Angiotensin-Aldosterone-System Blockade? Curr Hypertens Rev. 2018; 14(1):39-47.Curr Hypertens Rev2018-01-01T00:00:002018Determinants of Progression in Early Autosomal Dominant Polycystic Kidney Disease: Is it Blood Pressure or Renin-Angiotensin-Aldosterone-System Blockade?Authorship 179105129609976Brosnahan GM, Moore CG, Abebe KZAmerican journal of kidney diseases : the official journal of the National Kidney FoundationBrosnahan GM, Moore CG, Abebe KZ. In Reply to 'Artificial Intelligence Can Predict GFR Decline During the Course of ADPKD' and 'Linear and Nonlinear Estimated GFR Slopes in ADPKD Patients Reaching ESRD'. Am J Kidney Dis. 2018 06; 71(6):913.Am J Kidney Dis2018-03-30T00:00:002018In Reply to 'Artificial Intelligence Can Predict GFR Decline During the Course of ADPKD' and 'Linear and Nonlinear Estimated GFR Slopes in ADPKD Patients Reaching ESRD'.Authorship 1818591529854969Dad T, Abebe KZ, Bae KT, Comer D, Torres VE, Czarnecki PG, Schrier RW, Steinman TI, Moore CG, Chapman AB, Kaya D, Tao C, Braun WE, Winklhofer FT, Brosnahan G, Hogan MC, Miskulin DC, Rahbari Oskoui F, Flessner MF, Perrone RDKidney international reportsDad T, Abebe KZ, Bae KT, Comer D, Torres VE, Czarnecki PG, Schrier RW, Steinman TI, Moore CG, Chapman AB, Kaya D, Tao C, Braun WE, Winklhofer FT, Brosnahan G, Hogan MC, Miskulin DC, Rahbari Oskoui F, Flessner MF, Perrone RD. Longitudinal Assessment of Left Ventricular Mass in Autosomal Dominant Polycystic Kidney Disease. Kidney Int Rep. 2018 May; 3(3):619-624.Kidney Int Rep2018-01-06T00:00:002018Longitudinal Assessment of Left Ventricular Mass in Autosomal Dominant Polycystic Kidney Disease.D018450Physiology87425460.580771Disease ProgressionD007676Disorders1635190.651044Kidney Failure, ChronicD007668Anatomy42913550.570088KidneyREN GENERAL OPERATIONSD016891Disorders362090.771878Polycystic Kidney, Autosomal DominantD005919PhysiologyProcedures1736970.750294Glomerular Filtration RateSOM-MEDUniversity of Colorado Denver - Anschutz Medical CampusCharlesEdelsteinCharles Louis Edelstein39.74515960000000-104.840628000000001103Edelstein, CharlesProfessorMichelChoncholMichel Benjamin Chonchol39.74801570000000-104.834426300000001418Chonchol, MichelProfessorAlkeshJaniAlkesh Jani39.74515960000000-104.840628000000001473Jani, AlkeshProfessor5.300750.00590839135research areas2.374990.03549047coauthor of106.9185.33460similar to1137selected publicationsRichardJohnsonRichard J Johnson39.74515960000000-104.840628000000003114Johnson, RichardProfessorCarlosRoncalCarlos A Roncal39.74515960000000-104.840628000000003157Roncal, CarlosAssoc Professor-ResearchSwatiJainSwati Jain39.74515960000000-104.840628000000004006Jain, SwatiResearch Senior InstructorKristenNowakKristen Lynn Nowak39.74801570000000-104.834426300000004643Nowak, KristenAssociate ProfessorBetsyBritzBetsy Britz39.74515960000000-104.840628000000005396Britz, BetsyInstructorBereniceGitomerBerenice Y Gitomer39.74801570000000-104.834426300000001856Gitomer, BereniceProfessor-Research31844811Hanudel MR, Salusky IB, Pereira RC, Wang W, You Z, Nowak KL, Brosnahan GM, Torres VE, Chapman AB, Perrone RD, Steinman TI, Bae KT, Gitomer BY, Chonchol MBKidney international reportsHanudel MR, Salusky IB, Pereira RC, Wang W, You Z, Nowak KL, Brosnahan GM, Torres VE, Chapman AB, Perrone RD, Steinman TI, Bae KT, Gitomer BY, Chonchol MB. Erythropoietin and Fibroblast Growth Factor 23 in Autosomal Dominant Polycystic Kidney Disease Patients. Kidney Int Rep. 2019 Dec; 4(12):1742-1748.Kidney Int Rep2019-08-24T00:00:002019Erythropoietin and Fibroblast Growth Factor 23 in Autosomal Dominant Polycystic Kidney Disease Patients.32807060Brosnahan GM, You Z, Wang W, Gitomer BY, Chonchol MCurrent hypertension reviewsBrosnahan GM, You Z, Wang W, Gitomer BY, Chonchol M. Serum Uric Acid and Progression of Autosomal Dominant Polycystic Kidney Disease: Results from the HALT PKD Trials. Curr Hypertens Rev. 2021; 17(3):228-237.Curr Hypertens Rev2021-01-01T00:00:002021Serum Uric Acid and Progression of Autosomal Dominant Polycystic Kidney Disease: Results from the HALT PKD Trials.CortneySteeleCortney Nicole Steele17141Steele, Cortney0000-0002-5701-1240Post-Doctoral FellowAuthorship 16186633305291Grau L, Gitomer B, McNair B, Wolf M, Harris P, Brosnahan G, Torres V, Steinman T, Yu A, Chapman A, Chonchol M, Nowak KLKidney360Grau L, Gitomer B, McNair B, Wolf M, Harris P, Brosnahan G, Torres V, Steinman T, Yu A, Chapman A, Chonchol M, Nowak KL. Interactions between FGF23 and Genotype in Autosomal Dominant Polycystic Kidney Disease. Kidney360. 2020 Jul; 1(7):648-656.Kidney3602020-07-30T00:00:002020Interactions between FGF23 and Genotype in Autosomal Dominant Polycystic Kidney Disease.Authorship 2465031Authorship 2474926Authorship 2481797Authorship 2480091Authorship 24790011Authorship 2470165Authorship 2472978Authorship 247638134391872Brosnahan GM, Wang W, Gitomer B, Struemph T, George D, You Z, Nowak KL, Klawitter J, Chonchol MBAmerican journal of kidney diseases : the official journal of the National Kidney FoundationBrosnahan GM, Wang W, Gitomer B, Struemph T, George D, You Z, Nowak KL, Klawitter J, Chonchol MB. Metformin Therapy in Autosomal Dominant Polycystic Kidney Disease: A Feasibility Study. Am J Kidney Dis. 2022 04; 79(4):518-526.Am J Kidney Dis2021-08-12T00:00:002021Metformin Therapy in Autosomal Dominant Polycystic Kidney Disease: A Feasibility Study.34401721Nowak KL, Murray K, You Z, Gitomer B, Brosnahan G, Abebe KZ, Braun W, Chapman A, Harris PC, Miskulin D, Perrone R, Torres V, Steinman T, Yu A, Chonchol MKidney medicineNowak KL, Murray K, You Z, Gitomer B, Brosnahan G, Abebe KZ, Braun W, Chapman A, Harris PC, Miskulin D, Perrone R, Torres V, Steinman T, Yu A, Chonchol M. Pain and Obesity in Autosomal Dominant Polycystic Kidney Disease: A Post Hoc Analysis of the Halt Progression of Polycystic Kidney Disease (HALT-PKD) Studies. Kidney Med. 2021 Jul-Aug; 3(4):536-545.e1.Kidney Med2021-04-24T00:00:002021Pain and Obesity in Autosomal Dominant Polycystic Kidney Disease: A Post Hoc Analysis of the Halt Progression of Polycystic Kidney Disease (HALT-PKD) Studies.32634120Lavu S, Vaughan LE, Senum SR, Kline TL, Chapman AB, Perrone RD, Mrug M, Braun WE, Steinman TI, Rahbari-Oskoui FF, Brosnahan GM, Bae KT, Landsittel D, Chebib FT, Yu AS, Torres VE, Harris PCJCI insightLavu S, Vaughan LE, Senum SR, Kline TL, Chapman AB, Perrone RD, Mrug M, Braun WE, Steinman TI, Rahbari-Oskoui FF, Brosnahan GM, Bae KT, Landsittel D, Chebib FT, Yu AS, Torres VE, Harris PC. The value of genotypic and imaging information to predict functional and structural outcomes in ADPKD. JCI Insight. 2020 08 06; 5(15).JCI Insight2020-08-06T00:00:002020The value of genotypic and imaging information to predict functional and structural outcomes in ADPKD.33015606Brosnahan GKidney medicineBrosnahan G. Quest for the Cure: Testing the Old and New to Prevent Progression of Autosomal Dominant Polycystic Kidney Disease. Kidney Med. 2019 Nov-Dec; 1(6):329-331.Kidney Med2019-10-31T00:00:002019Quest for the Cure: Testing the Old and New to Prevent Progression of Autosomal Dominant Polycystic Kidney Disease.32487558Bae KT, Shi T, Tao C, Yu ASL, Torres VE, Perrone RD, Chapman AB, Brosnahan G, Steinman TI, Braun WE, Srivastava A, Irazabal MV, Abebe KZ, Harris PC, Landsittel DPJournal of the American Society of Nephrology : JASNBae KT, Shi T, Tao C, Yu ASL, Torres VE, Perrone RD, Chapman AB, Brosnahan G, Steinman TI, Braun WE, Srivastava A, Irazabal MV, Abebe KZ, Harris PC, Landsittel DP. Expanded Imaging Classification of Autosomal Dominant Polycystic Kidney Disease. J Am Soc Nephrol. 2020 07; 31(7):1640-1651.J Am Soc Nephrol2020-06-02T00:00:002020Expanded Imaging Classification of Autosomal Dominant Polycystic Kidney Disease.Authorship 255423435005320Steele C, You Z, Gitomer BY, Brosnahan GM, Abebe KZ, Braun WE, Chapman AB, Harris PC, Perrone RD, Steinman TI, Torres VE, Yu ASL, Chonchol M, Nowak KLKidney international reportsSteele C, You Z, Gitomer BY, Brosnahan GM, Abebe KZ, Braun WE, Chapman AB, Harris PC, Perrone RD, Steinman TI, Torres VE, Yu ASL, Chonchol M, Nowak KL. PKD1 Compared With PKD2 Genotype and Cardiac Hospitalizations in the Halt Progression of Polycystic Kidney Disease Studies. Kidney Int Rep. 2022 Jan; 7(1):117-120.Kidney Int Rep2021-10-07T00:00:002021PKD1 Compared With PKD2 Genotype and Cardiac Hospitalizations in the Halt Progression of Polycystic Kidney Disease Studies.Authorship 257673835217526Bae KT, Tao C, Feldman R, Yu ASL, Torres VE, Perrone RD, Chapman AB, Brosnahan G, Steinman TI, Braun WE, Mrug M, Bennett WM, Harris PC, Srivastava A, Landsittel DP, Abebe KZClinical journal of the American Society of Nephrology : CJASNBae KT, Tao C, Feldman R, Yu ASL, Torres VE, Perrone RD, Chapman AB, Brosnahan G, Steinman TI, Braun WE, Mrug M, Bennett WM, Harris PC, Srivastava A, Landsittel DP, Abebe KZ. Volume Progression and Imaging Classification of Polycystic Liver in Early Autosomal Dominant Polycystic Kidney Disease. Clin J Am Soc Nephrol. 2022 03; 17(3):374-384.Clin J Am Soc Nephrol2022-02-25T00:00:002022Volume Progression and Imaging Classification of Polycystic Liver in Early Autosomal Dominant Polycystic Kidney Disease.Authorship 232931true1ProfessorProfessortrue1ProfessorProfessortrue1Assoc Professor-ResearchAssoc Professor-Researchtrue1Post-Doctoral FellowPost-Doctoral Fellowtrue1Professor-ResearchProfessor-Researchtrue1Asst ProfessorAsst Professortrue1AffiliateAffiliatetrue1Assoc Professor-ResearchAssoc Professor-Researchtrue1Research Senior InstructorResearch Senior Instructortrue1InstructorInstructortrue1ProfessorProfessortrue1Associate ProfessorAssociate Professortrue1ProfessorProfessorAuthorship 551162Authorship 575775Authorship 669647Authorship 751281Authorship 117399224925719Schrier RW, Brosnahan G, Cadnapaphornchai MA, Chonchol M, Friend K, Gitomer B, Rossetti SJournal of the American Society of Nephrology : JASNSchrier RW, Brosnahan G, Cadnapaphornchai MA, Chonchol M, Friend K, Gitomer B, Rossetti S. Predictors of autosomal dominant polycystic kidney disease progression. J Am Soc Nephrol. 2014 Nov; 25(11):2399-418.J Am Soc Nephrol2014-06-12T00:00:002014Predictors of autosomal dominant polycystic kidney disease progression.Authorship 777831